FDA NDC Directory · JSON-LD · Markdown

Repaglinide

NDC 65862-671 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA203820
Dosage form / routeTABLET · ORAL
Active ingredientsREPAGLINIDE (1 mg/1)
Marketing started20140122
Package count3

External sources

Source: openFDA. Public-domain (CC0).